Overview

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

Status:
Completed
Trial end date:
2016-11-29
Target enrollment:
Participant gender:
Summary
The Macimorelin Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, 2-way crossover Trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.
Phase:
Phase 3
Details
Lead Sponsor:
AEterna Zentaris
Treatments:
Hormones
Insulin
Insulin, Globin Zinc